AzTrials
AzTrials

ElderlyPROFACTHOSNCT07475442

Prognostic Factors of Hospitalization for Patients Aged 75 and Over in Emergency Department in France - Monocentric Retrospective Cohort Study

An observational study of Elderly and Emergency Departments, run by Poitiers University Hospital at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

A geriatric patient is defined as a patient aged 75 and over who meets certain medical or social vulnerability criteria and is characterised by coexisting physical and/or psychological dependence. The proportion of patients with a geriatric profile in the general population is growing. Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Elderly, Emergency Departments, Prognostic Factors
How many people
967 participants
Where
1 siteFrance
Study dates
15 Mar 2026to 15 Apr 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Elderly patients, over or equal 75 years old, admitted to the emergency department in the inclusion period

Who may be able to join

  • Adult over or equal 75 years old
  • Patient admitted to the emergency department between 10/01/2022 and 09/30/2023 for the second group, and between 10/01/2024 and 09/30/2025 for the first group
  • Patient and/or family and/or trusteeship who doesn't refused to participate

Who cannot join

  • Patient died before admitted to emergency department
  • Patient already included in the study
  • File created by mistake, identified by the mention "Erreur de dossier"
  • Patient deprived of total or partial liberty by a judicial or administrative decision

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Manon BOILLET, Advanced Practice Nurse contact

+33 05 49 44 44 44 ext. 45340

manon.boillet@chu-poitiers.fr

Christine SZCZUCZYNSKI, Advanced Practice Nurse contact

+33 05 49 44 44 ext. 45734

christine.szczuczynski@chu-poitiers.fr

France1 site
  • CHU Poitiers

    Poitiers, France, 86021

    Manon BOILLET, Advanced Practice Nurse, +33 05 49 44 44 44 ext. 45340, manon.boillet@chu-poitiers.fr

    Christine SZCZUCZYNSKI, Advanced Practice Nurse, +33 05 49 44 44 44 ext. 45734, christine.szczuczynski@chu-poitiers.fr

Other trials in France

About this study

Official title: Prognostic Factors of Hospitalization for Patients Aged 75 and Over in Emergency Department in France - Monocentric Retrospective Cohort Study - PROFACTHOS

A geriatric patient is defined as a patient aged 75 and over who meets certain medical or social vulnerability criteria and is characterised by coexisting physical and/or psychological dependence. The proportion of patients with a geriatric profile in the general population is growing. The average time spent in the emergency department by the elderly population is about 3 hours longer than for patients under 75 years old in France, which is associated with the risk of decompensation of chronic conditions, confusion, falls or agitation. An overnight stay in the emergency department for these patients increases the risk of mortality and the length of hospital stay.

Several prognostic scores for hospitalization have been studied in adult populations. The most widely used scores are the Sydney Triage to Admission Risk Tool (START), the Ambulatory (AMB) and the Glasgow Admission Prediction Score (GAPS). Studies have compared these three scores and demonstrated the greater robustness of GAPS. The CalcuLation of the Elderly Admission Risk in the Emergency Department (CLEARED) tool, developed for the elderly population, has lower performance than GAPS. A systematic review of the literature studied the power of GAPS for the geriatric population and highlighted the need for validation in the target population. No validated hospitalization prognostic score was found in France for this population. The research hypothesis is that GAPS would detect hight probability of admission at the time of triage for the patients aged 75 and over in emergency department in France. The primary objective of this monocentric study is to evaluate the prognostic performance of GAPS for the target population (on the group 1). The secondary objectives consist of developing and internally validating a new score (PROFACTHOS) (on the group 2), then performing a temporal validation of PROFACTHOS with comparison to the GAPS (on the group 1), and finally to determine the threshold for classifying patients with a high probability of hospitalization for the score with the strongest discriminatory performance among GAPS or PROFACTHOS.

Read more

Group 1: Patients aged 75 and over admitted to emergency department from 10/01/2024 to 09/30/2025.

Group 2 : Patients aged 75 and over admitted to emergency department from 10/01/2022 to 09/30/2023

Medical subject headings
Emergencies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To evaluate the prognostic performance of GAPS in a population of patients aged 75 and over admitted to emergency departments in France

    The performance of GAPS will be evaluated by measuring the area under the ROC (receiver operating characteristic) curve (AUC) with the population of group 1.

    Measured: 1 day

Secondary outcomes (4)
  1. To develop a prognostic hospitalization score (PROFACTHOS) based on data from the patient's initial clinical exam.

    The PROFACTHOS prognostic score will be developed to predict the following binary event: hospitalization of the patient at the end of treatment. Potential predictive factors were established based on existing literature and by consulting a team of emergency physicians and geriatricians at Poitiers University Hospital. The performance of the prognostic score will be evaluated using the AUC (area under the ROC curve) and the Brier score. It will be carried out with the population of group 2.

    Measured: 1 day

  2. Temporal validation of the hospitalization prognostic score PROFACTHOS

    The PROFACTHOS hospitalization prognostic score will be temporally validated using data from a time period independent of that used for its construction, with patients from group 1. The performance of the score will be measured by the area under the ROC (receiver operating characteristic) curve (AUC) and the Brier score.

    Measured: 1 day

  3. To compare the performance of both scores GAPS and PROFACTHOS

    The prognostic performance of the GAPS and PROFACTHOS scores will be evaluated and compared by their AUC, with patients from group 1.

    Measured: 1 day

  4. To determine the threshold for classifying patients with a high probability of hospitalization for the score with the strongest discriminatory performance among GAPS or PROFACTHOS

    The threshold will be determined in order to obtain optimal positive and negative predictive values.

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2026
  2. Study start15 Mar 2026 (estimated)
  3. Primary completion15 Mar 2027 (estimated)
  4. Study completion15 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
967 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07475442
Sponsor's protocol ID
PROFACTHOS
Acronym
PROFACTHOS
Status last verified
Mar 2026
First submitted
10 Mar 2026
Last updated
16 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Elderly and Emergency Departments, run by Poitiers University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Manon BOILLET, Advanced Practice Nurse (+33 05 49 44 44 44 ext. 45340, manon.boillet@chu-poitiers.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To evaluate the prognostic performance of GAPS in a population of patients aged 75 and over admitted to emergency departments in France (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in